trending Market Intelligence /marketintelligence/en/news-insights/trending/w_sj5cd9tnded_2awtqwlw2 content esgSubNav
In This List

HLS Therapeutics names CFO

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


HLS Therapeutics names CFO

HLS Therapeutics Inc. appointed Tim Hendrickson as CFO, effective Sept. 6.

Hendrickson previously was the company's vice president of finance and administration, a position he has held since 2015.

Toronto-based HLS Therapeutics acquires and distributes in North American markets pharmaceutical products for the central nervous system and cardiovascular specialties.